Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue
Creator
Jiang, Shibo
Lu, Lu
Xu, Wei
Rong, Lijun
Wang, Qian
Li, Weihua
Zou, Peng
Wang, Tian
Hu, Jingying
Meng, Yu
Si, Lulu
Wang, Yuzhu
Xia, Minjie
Li, Tian
Ojcius, David
Meng, Si
Source
Medline; PMC
abstract
Zika virus (ZIKV) was a re-emerging arbovirus associated with Guillain–Barré Syndrome in adult and congenital Zika syndrome in fetus and infant. Although ZIKV was mainly transmitted by mosquito bites, many sexual transmission cases have been reported since the outbreak in 2015. ZIKV can persist in testis and semen for a long time, causing testicular tissue damage and reducing sperm quality. However, no drug has been approved for prevention or treatment of ZIKV infection, especially infection in male testicular tissue. Previously reported peptide Z2 could inactivate ZIKV, inhibiting ZIKV infection in vitro and in vivo. Importantly, Z2 could inhibit vertical transmission of ZIKV in pregnant mice, reducing ZIKV infection in fetus. Here we showed that intraperitoneally administered Z2 could also be distributed to testis and epididymis, resulting in the reduction of ZIKV RNA copies in testicular tissue and protection of testis and epididymis against ZIKV-induced pathological damage and poor sperm quality in type I interferon receptor-deficient A129 mice. Thus, Z2, a ZIKV inactivator, could serve as an antiviral agent for treatment of ZIKV infection and attenuation of ZIKV-induced testicular tissue damage.
has issue date
2019-09-27
(
xsd:dateTime
)
bibo:doi
10.3389/fmicb.2019.02250
bibo:pmid
31611865
has license
cc-by
sha1sum (hex)
e4813a9f4fee2d74c954d90bed67e8738047a390
schema:url
https://doi.org/10.3389/fmicb.2019.02250
resource representing a document's title
A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue
has PubMed Central identifier
PMC6777420
has PubMed identifier
31611865
schema:publication
Front Microbiol
resource representing a document's body
covid:e4813a9f4fee2d74c954d90bed67e8738047a390#body_text
is
schema:about
of
named entity 'DAMAGE'
named entity 'semen'
named entity 'cases'
named entity 'Although'
named entity 'intraperitoneally'
named entity 'ZIKA VIRUS'
named entity 'VIRUS'
named entity 'IN VITRO'
named entity 'APPROVED'
named entity 'MOSQUITO BITES'
named entity 'IN VIVO'
named entity 'CASES'
named entity 'ADMINISTERED'
named entity 'SYNDROME'
named entity 'ARBOVIRUS'
named entity 'ANTIVIRAL AGENT'
named entity 'DRUG'
named entity 'SEMEN'
named entity 'PATHOLOGICAL'
named entity 'WAS A'
named entity 'RESULTING IN'
named entity 'CAUSING'
named entity 'ASSOCIATED WITH'
named entity 'TESTIS'
named entity 'SEXUAL TRANSMISSION'
named entity 'SERVE'
named entity 'PREVENTION'
named entity 'HERE'
named entity 'MICE'
named entity 'TESTICULAR TISSUE'
named entity 'ZIKA VIRUS'
named entity 'LONG'
named entity 'PREGNANT'
named entity 'RNA'
named entity 'CONGENITAL ZIKA SYNDROME'
named entity 'INDUCED'
named entity 'VERTICAL TRANSMISSION'
named entity 'ADULT'
named entity 'PREVIOUSLY'
named entity 'INDUCED'
named entity 'BASED'
named entity 'CITATION'
named entity 'MALE'
named entity 'MICE'
named entity 'REDUCTION'
named entity 'INFANT'
named entity 'ATTENUATION'
named entity 'POOR'
named entity '2015'
named entity 'COPIES'
named entity 'FETUS'
named entity 'REPORTED'
named entity 'PROTECTION'
named entity 'DAMAGE'
named entity 'TIME'
named entity 'BARR'
named entity 'TESTICULAR TISSUE'
named entity 'PEPTIDE'
named entity 'INHIBITING'
named entity 'DISTRIBUTED'
named entity 'DEFICIENT'
named entity 'TISSUE DAMAGE'
named entity 'HAVE'
named entity 'OUTBREAK'
named entity 'MALE'
named entity 'TYPE I INTERFERON RECEPTOR'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software